Publications by authors named "O Taboga"

Article Synopsis
  • - Chikungunya fever, caused by the chikungunya virus (CHIKV), leads to acute arthritis that may develop into chronic pain, with a recently approved vaccine not widely accessible in endemic areas.
  • - A new vectored vaccine using baculovirus technology shows promise by presenting CHIKV proteins E1 and E2 on its surface, eliciting strong immune responses in tested mice, including the production of neutralizing antibodies.
  • - Mice receiving two doses of this baculovirus-based vaccine were fully protected from CHIKV infection, highlighting its potential as an effective vaccine platform against this re-emerging disease amidst its surge in cases, particularly in the Americas.
View Article and Find Full Text PDF

Bovine tuberculosis (bTB) represents a threat to livestock production. Mycobacterium bovis is the main causative agent of bTB and a pathogen capable of infecting wildlife and humans. Eradication programs based on surveillance in slaughterhouses with mandatory testing and culling of reactive cattle have failed to eradicate bTB in many regions worldwide.

View Article and Find Full Text PDF

The occlusion bodies of Autographa californica multiple nucleopolyhedrovirus are proteinaceous formations with significant biotechnological potential owing to their capacity to integrate foreign proteins through fusion with polyhedrin, their primary component. However, the strategy for successful heterologous protein inclusion still requires further refinement. In this study, we conducted a comparative assessment of various conditions to achieve the embedding of recombinant proteins within polyhedra.

View Article and Find Full Text PDF

Chagas' is a neglected disease caused by the eukaryotic kinetoplastid parasite, Currently, approximately 8 million people are infected worldwide, most of whom are in the chronic phase of the disease, which involves cardiac, digestive, or neurologic manifestations. There is an urgent need for a vaccine because treatments are only effective in the initial phase of infection, which is generally underdiagnosed. The selection and combination of antigens, adjuvants, and delivery platforms for vaccine formulations should be designed to trigger mixed humoral and cellular immune responses, considering that has a complex life cycle with both intracellular and bloodstream circulating parasite stages in vertebrate hosts.

View Article and Find Full Text PDF